We found that the mRNA levels of both SLC2A1 and SLC2A3 were significantly upregulated in cancer tissues of these CRC patients (Fig. 1d, Supplementary Fig. S1j–l). The gene discussed is SLC2A3; the disease is colorectal carcinoma.